Current status:
Cancelled Pre Market
Current status date:
2018-07-24
DIN:
02264609
Electronic product monograph is not available
Route(s) of administration:
Inhalation
Number of active ingredient(s):
2
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS):
See footnote 3
12:12.08.12
,
12:08.08
,
48:12.04.12
Anatomical Therapeutic Chemical (ATC):
See footnote 4
R03AL02 SALBUTAMOL AND IPRATROPIUM BROMIDE
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
IPRATROPIUM BROMIDE
|
0.5 MG / 2.5 ML
|
SALBUTAMOL (SALBUTAMOL SULFATE)
|
2.5 MG / 2.5 ML
|